ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $638,344 | -4.6% | 5,220 | -0.9% | 0.02% | -3.8% |
Q2 2023 | $669,069 | -1.7% | 5,270 | 0.0% | 0.03% | -3.7% |
Q1 2023 | $680,661 | -10.4% | 5,270 | -9.0% | 0.03% | -12.9% |
Q4 2022 | $760,001 | +13.4% | 5,789 | +1.1% | 0.03% | +3.3% |
Q3 2022 | $670,000 | -0.9% | 5,726 | -0.4% | 0.03% | +3.4% |
Q2 2022 | $676,000 | -12.1% | 5,751 | -2.6% | 0.03% | 0.0% |
Q1 2022 | $769,000 | -12.4% | 5,904 | +2.6% | 0.03% | -9.4% |
Q4 2021 | $878,000 | -1.9% | 5,754 | +3.9% | 0.03% | -11.1% |
Q3 2021 | $895,000 | -2.3% | 5,538 | -1.1% | 0.04% | -2.7% |
Q2 2021 | $916,000 | +5.7% | 5,600 | -2.8% | 0.04% | 0.0% |
Q1 2021 | $867,000 | -0.2% | 5,762 | +0.4% | 0.04% | -7.5% |
Q4 2020 | $869,000 | +11.8% | 5,737 | 0.0% | 0.04% | +2.6% |
Q3 2020 | $777,000 | -0.9% | 5,737 | +0.0% | 0.04% | -7.1% |
Q2 2020 | $784,000 | +26.9% | 5,736 | 0.0% | 0.04% | +10.5% |
Q1 2020 | $618,000 | -9.6% | 5,736 | +1.1% | 0.04% | +8.6% |
Q4 2019 | $684,000 | +14.6% | 5,673 | -5.4% | 0.04% | 0.0% |
Q3 2019 | $597,000 | -17.5% | 5,999 | -9.6% | 0.04% | -20.5% |
Q2 2019 | $724,000 | -2.2% | 6,638 | +0.3% | 0.04% | -10.2% |
Q1 2019 | $740,000 | +17.8% | 6,617 | +1.5% | 0.05% | 0.0% |
Q4 2018 | $628,000 | +39.9% | 6,517 | +76.9% | 0.05% | +58.1% |
Q3 2018 | $449,000 | +93.5% | 3,684 | +436.2% | 0.03% | +40.9% |
Q4 2015 | $232,000 | -11.5% | 687 | -20.4% | 0.02% | -15.4% |
Q3 2015 | $262,000 | -35.9% | 863 | -22.1% | 0.03% | -33.3% |
Q2 2015 | $409,000 | -69.5% | 1,108 | -71.6% | 0.04% | -66.7% |
Q1 2015 | $1,342,000 | +11.3% | 3,908 | -1.7% | 0.12% | +5.4% |
Q4 2014 | $1,206,000 | +12.7% | 3,977 | +1.7% | 0.11% | +6.7% |
Q3 2014 | $1,070,000 | +8.4% | 3,912 | +1.9% | 0.10% | +7.2% |
Q2 2014 | $987,000 | +15.3% | 3,838 | +6.0% | 0.10% | +4.3% |
Q1 2014 | $856,000 | +7.5% | 3,621 | +3.3% | 0.09% | 0.0% |
Q4 2013 | $796,000 | +57.0% | 3,505 | +44.9% | 0.09% | +38.8% |
Q3 2013 | $507,000 | +57.0% | 2,419 | +30.4% | 0.07% | +45.7% |
Q2 2013 | $323,000 | – | 1,855 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |